Build an Autonomous AI Agent System in Under 30 Minutes

Learn how to set up a secure and efficient OpenClaw multi-agent system in just 26 minutes. This guide covers hardware, AI ...
The Lancet

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Among patients with ...